Fanconi Anemia in Children is a rare genetic disorder, but it has a significant impact on a child’s health and daily life. The disease affects the bone marrow and the body’s ability to produce healthy blood cells, leading to issues such as persistent fatigue, easy bruising, and an increased risk of infections. In this Medikal Guide article, we will explore the causes of Fanconi anemia, its symptoms in children, accurate diagnostic methods, and the latest treatment and care strategies, so parents can effectively monitor their child’s condition and reduce complications.
Fanconi Anemia (FA) is a rare inherited type of anemia caused by Fanconi syndrome. This disorder affects the bone marrow, reducing the body’s ability to produce healthy blood cells, which leads to problems with blood, immunity, and growth.
The main cause is a defective gene:
The child inherits a faulty copy of the gene from both parents.
In rare cases, a new mutation can occur without a family history.
Paleness and persistent fatigue due to anemia
Easy bruising or bleeding caused by low platelets
Weak immunity and recurrent infections
Growth problems and congenital abnormalities in hands or bones
Diagnosis relies on a combination of medical exams, laboratory tests, and genetic testing:
Clinical Examination
Observing symptoms like fatigue, paleness, easy bruising, or congenital anomalies.
Blood Tests
Complete Blood Count (CBC): evaluates red and white blood cells and platelets.
Bone Marrow Biopsy: assesses blood cell production and marrow health.
Chromosome Breakage Test
Measures the ability of cells to repair DNA damage.
Abnormal chromosome breaks strongly indicate Fanconi anemia.
Genetic Testing
Detects mutations in FA-related genes such as FANCA, FANCC, FANCG.
Confirms the diagnosis and identifies the type of inheritance.
Medications do not cure the disease, but they help:
Increase blood cell production
Prevent infections
Support platelet function as needed
Bone Marrow Transplant: the most important surgical intervention for permanent treatment.
Sometimes children require surgery to correct bone deformities or congenital heart/kidney issues.
Depends on the severity of the condition and the treatment plan.
Most children need lifelong medical follow-up.
Higher risk of cancer, especially leukemia.
No, it is a genetic condition.
Early diagnosis and regular monitoring improve quality of life and reduce complications.
Is Fanconi anemia contagious?
No, it is inherited, not infectious. The child cannot transmit it to others.
Do all children show the same symptoms?
No, symptoms vary depending on the severity and the gene involved. Some children have very mild symptoms; others show them at birth.
When do symptoms usually appear?
Some children show blood problems in infancy or early childhood.
Others may develop symptoms years later.
Do children need regular blood transfusions?
Some children require periodic transfusions if bone marrow cannot produce enough blood cells, especially before a transplant or during infections.
Can children attend school and play with peers?
Most can, but activities should be supervised by a doctor if the child has severe immune weakness or frequent bleeding.
Is bone marrow transplant the final solution?
Yes, it is currently the only treatment that can cure Fanconi anemia.
Success depends on: donor match, post-transplant care, and overall health of the child.
Can affected children have children in the future?
Some may have puberty or fertility issues, but with treatment and medical support, fertility may be possible.
Are there new treatments being studied?
Yes, gene therapy is being explored to correct genetic mutations, but it is still in clinical trials.
Fanconi anemia is characterized by:
Multiple physical abnormalities
Bone marrow failure
Increased risk of cancer
Mutations in at least 15 different genes can cause FA. Normally, these genes produce proteins that repair damaged DNA in blood stem cells and other cells. In FA, DNA repair is slow, leading to stem cell death and impaired blood production.
Usually diagnosed between birth and ages 10–15, but can appear in adulthood.
Affects both boys and girls across all ethnic groups.
FANCA: most common (~60–70% of cases)
FANCC
FANCG
Other genes: FANCB, FANCD2, FANCE, etc.
Each gene may influence symptom severity and onset.
Autosomal Recessive: most cases; child inherits faulty gene from both parents.
X-linked: very rare; usually affects boys only.
Classic FA: clear symptoms from childhood, severe blood problems, congenital abnormalities.
Adult-onset / Mild FA: mild early symptoms; blood problems or cancer may appear later.
Genetic Inheritance:
Child inherits faulty gene from both parents.
Over 20 genes are associated, including FANCA, FANCC, FANCG.
In Fanconi anemia, the body’s cells cannot repair DNA damage properly, leading to anemia, bone marrow problems, and an increased risk of cancer.
In some cases, a new (de novo) mutation occurs without any family history.
Fanconi anemia presents with multiple symptoms, some related to blood and bone marrow problems, and others that are congenital (present at birth):
Anemia: child appears pale and fatigued; may tire quickly during play
Low platelets: minor gum bleeding or easy bruising
Low white blood cells: increased susceptibility to infections
Small size or slow growth
Bone abnormalities, especially in the hands (malformed or missing thumbs or wrists)
Kidney or urinary tract problems
Facial abnormalities such as wide-set eyes or distinctive nose and mouth shapes
Occasionally, heart defects
Delayed puberty
Increased risk of certain cancers, especially leukemia
Note: Not all children exhibit all symptoms, and some cases may show very mild early symptoms.
Fanconi anemia does not have precisely defined stages, but symptoms tend to progress over time:
Pale appearance due to mild anemia
Minor bruising or slight gum bleeding
Small growth delays (short stature or low weight)
Some children may have congenital abnormalities in the hands, kidneys, or heart
Usually appears between ages 4–10
Worsening anemia → fatigue, weakness, paleness
Low platelets → easier bleeding and bruising
Low white blood cells → increased risk of infections
Delayed puberty in some children
Bone, heart, or kidney problems become more pronounced
Slower growth compared to peers
Higher likelihood of certain cancers, especially:
Leukemia
Other solid tumors
Severe anemia → fatigue, paleness, general weakness
Low platelets → spontaneous bleeding and bruising
Low white blood cells → frequent and serious infections
Short stature or low weight
Bone deformities, particularly in hands and fingers
Congenital abnormalities in kidneys, heart, or urinary system
Delayed puberty
Occasional difficulty with fertility due to hormonal problems
Higher risk of specific cancers:
Leukemia
Solid tumors in digestive system or skin
Chronic fatigue and illness can affect daily life
Difficulty participating in normal childhood activities due to immune weakness or tiredness
Diagnosis requires accurate testing to guide treatment and care:
Physician observes for symptoms such as:
Fatigue and persistent paleness
Easy bruising or bleeding
Slow growth or congenital hand/face abnormalities
Complete Blood Count (CBC): checks red blood cells, white blood cells, and platelets
Bone Marrow Function Tests: including biopsy or aspiration to assess blood production
A distinctive test for Fanconi anemia
Measures the child’s cells’ ability to repair DNA damage
Abnormal chromosomal breaks strongly indicate FA
Detects mutations in FA genes such as FANCA, FANCC, FANCG
Confirms diagnosis and identifies subtype and inheritance pattern
X-rays of bones: if hand deformities are present
Heart or kidney imaging: if congenital anomalies are suspected
Medication cannot cure FA, but helps:
Improve blood cell function
Prevent complications
Support overall health
Erythropoietin: stimulates red blood cell production, reduces anemia, and fatigue
Colony-Stimulating Factors (G-CSF or GM-CSF): stimulate white blood cell production, reduce infection risk
Iron, folic acid, vitamin B12: improve blood production depending on the child’s condition
Antibiotics, antivirals, antifungals for children with severe white blood cell deficiencies
Sometimes medications are given to reduce bleeding or support platelets
Often dependent on platelet transfusions when needed
Treatment depends on multiple factors:
Child’s age, general health, and medical history
Disease severity and body impact
Tolerance to medications or procedures
Expected disease course and potential complications
Parental preferences and choices
Hormones that improve blood counts in ~50% of patients
Taken daily orally (liquid or tablets)
Possible side effects: fluid retention, high blood pressure, nausea, vomiting, acne, oily skin, genital enlargement, voice changes, hair growth or loss, behavioral changes, hot flashes, breast enlargement or pain, menstrual irregularities, liver toxicity
G-CSF or GM-CSF to stimulate white blood cell production
May also improve red blood cells and platelets
Administered via injection
The only definitive treatment for FA-related blood problems
Replaces diseased stem cells with healthy donor cells
Success depends on donor match (siblings preferred), child’s age, and marrow condition
Risks include sensitivity to chemo/radiation and transplant complications
Not all children are candidates; decisions must be made with a hematologist and transplant team
New treatment options are under study for safer and more effective future therapies
Most children require ongoing bone marrow monitoring
May need blood transfusions or supportive therapy
Some cases may progress to bone marrow failure
Higher risk for leukemia and other solid tumors
Regular genetic and laboratory follow-ups help early detection
Short stature or delayed growth may persist
Bone or kidney problems may continue lifelong
Supportive care like physical therapy improves quality of life
Fatigue and immune deficiencies may limit activities
Psychological and social support is crucial for adaptation
Stem cell transplant may be needed if marrow fails or serious complications arise
Includes infection prevention, periodic blood transfusions, and close follow-up with a specialized medical team